FreeCast (CAST) Signs Kind Wireless Platform Agreement

New to The Street Show #777 features executives from Stewards Investment Capital, BioVie (NASDAQ:BIVI), FreeCast (NASDAQ:CAST), and American Fusion (OTCQB:AMFN). BioVie reports positive long COVID and Parkinson's trial results. FreeCast discusses its media monetization technology. American Fusion presents its fusion power technology. The show airs on Bloomberg Television and YouTube.

FreeCast, Inc. [CAST] reported a 13% revenue increase to $710,882, driven by advertising and FAST services. Net loss narrowed to $13.0 million, and subscriber count rose to 1.19 million. A $23.7 million private placement improved liquidity, and gross margin increased to 82%.

Jefferies upgraded Castellum AB to hold from underperform and raised its price target to SEK125 from SEK105, citing planned SEK15.6 billion share buybacks in 2026-27 (25% of Dec 2025 shares) and revised forecasts. Jefferies expects EPS of SEK8.45 for 2026 and notes weak office demand, with 2026-27 credit metrics remaining tight.

Investing.com reports Castellum AB shares fell 4.7% to SEK 126.6. UBS downgraded Castellum from Buy to Neutral, saying about 25% YTD gains and prior rerating drivers, including over SEK 20bn in disposals and buybacks, are largely priced in. Barclays upgraded to Equal Weight and raised its target to SEK 130 but cut 2026 EPS by 8% and 2027 by 7%.

Castro Model (TASE: CAST) said it signed a five-year franchise agreement with China’s Anta Sports Products to distribute and sell Anta in Israel. The deal includes wholesale licensing, dedicated stores, and a local website, with estimated investment of NIS 30m and start in 2027. Castro may seek partners for up to 49% of a subsidiary; Anta is HK-listed with 2025 revenue of $11.6b.

Barclays upgraded Castellum AB (ST:CAST) to Equal Weight from Underweight and raised its price target to SEK130 from SEK105, citing confidence in management execution after ~SEK18bn asset disposals and plans to return proceeds via buybacks. Barclays expects ~60% of proceeds for repurchases and 40% for debt reduction, but cut recurring EPS forecasts for 2026/2027.